[HTML][HTML] Virus-like particle vaccines and platforms for vaccine development

M Kheirvari, H Liu, E Tumban - Viruses, 2023 - mdpi.com
Virus-like particles (VLPs) have gained a lot of interest within the past two decades. The use
of VLP-based vaccines to protect against three infectious agents—hepatitis B virus, human …

Virus-like Particle Vaccines and Platforms for Vaccine Development

M Kheirvari, H Liu, E Tumban - Viruses, 2023 - pubmed.ncbi.nlm.nih.gov
Virus-like particles (VLPs) have gained a lot of interest within the past two decades. The use
of VLP-based vaccines to protect against three infectious agents-hepatitis B virus, human …

Virus-like Particle Vaccines and Platforms for Vaccine Development.

M Kheirvari, H Liu, E Tumban - Viruses, 2023 - go.gale.com
Virus-like particles (VLPs) have gained a lot of interest within the past two decades. The use
of VLP-based vaccines to protect against three infectious agents—hepatitis B virus, human …

Virus-like Particle Vaccines and Platforms for Vaccine Development.

M Kheirvari, H Liu, E Tumban - Viruses, 2023 - europepmc.org
Virus-like particles (VLPs) have gained a lot of interest within the past two decades. The use
of VLP-based vaccines to protect against three infectious agents—hepatitis B virus, human …

[PDF][PDF] Virus-like Particle Vaccines and Platforms for Vaccine Development. Viruses 2023, 15, 1109

M Kheirvari, H Liu, E Tumban - 2023 - researchgate.net
Virus-like particles (VLPs) have gained a lot of interest within the past two decades. The use
of VLP-based vaccines to protect against three infectious agents—hepatitis B virus, human …

Virus-like Particle Vaccines and Platforms for Vaccine Development.

M Kheirvari, H Liu, E Tumban - Viruses (1999-4915), 2023 - search.ebscohost.com
Virus-like particles (VLPs) have gained a lot of interest within the past two decades. The use
of VLP-based vaccines to protect against three infectious agents—hepatitis B virus, human …

[HTML][HTML] Virus-like Particle Vaccines and Platforms for Vaccine Development

M Kheirvari, H Liu, E Tumban - Viruses, 2023 - ncbi.nlm.nih.gov
Virus-like particles (VLPs) have gained a lot of interest within the past two decades. The use
of VLP-based vaccines to protect against three infectious agents—hepatitis B virus, human …

[PDF][PDF] Virus-like Particle Vaccines and Platforms for Vaccine Development. Viruses 2023, 15, 1109

M Kheirvari, H Liu, E Tumban - 2023 - pdfs.semanticscholar.org
Virus-like particles (VLPs) have gained a lot of interest within the past two decades. The use
of VLP-based vaccines to protect against three infectious agents—hepatitis B virus, human …

Virus-like Particle Vaccines and Platforms for Vaccine Development

M Kheirvari, H Liu, E Tumban - Viruses, 2023 - search.proquest.com
Virus-like particles (VLPs) have gained a lot of interest within the past two decades. The use
of VLP-based vaccines to protect against three infectious agents—hepatitis B virus, human …

Virus-like Particle Vaccines and Platforms for Vaccine Development.

M Kheirvari, H Liu, E Tumban - Viruses, 2023 - europepmc.org
Virus-like particles (VLPs) have gained a lot of interest within the past two decades. The use
of VLP-based vaccines to protect against three infectious agents-hepatitis B virus, human …